{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:59:56Z","timestamp":1792112396487,"version":"4.4.0"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460268"],"award-info":[{"award-number":["82460268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>As an emerging therapeutic strategy, stem cell transplantation has demonstrated promising potential in the management of refractory epilepsy. Epilepsy, a prevalent neurological disorder characterized by recurrent seizures, affects approximately one-third of patients worldwide who exhibit resistance to existing antiepileptic drugs (AEDs). Consequently, exploring novel treatment modalities is imperative. Recent studies have indicated that stem cell transplantation improves neurological function in epilepsy through multiple mechanisms. Research has revealed that transplanted stem cells mitigate seizure-induced neuronal damage by replacing dead or dysfunctional neurons, secreting beneficial neurotrophic factors (e.g., brain-derived neurotrophic factor, BDNF), and releasing anti-inflammatory cytokines. Preclinical studies and early-phase clinical trials have shown that stem cell transplantation significantly reduces seizure frequency and enhances patients\u2019 quality of life. However, current research is limited by small sample sizes and short-term follow-ups, necessitating further validation of long-term efficacy. Despite its therapeutic promise, stem cell transplantation faces critical challenges. First, technical details such as the cell source, processing, method of transplantation, and timing have yet to be standardized, leading to potential variability in efficacy and safety across different stem cell types. Second, complications like immune rejection and tumorigenesis pose significant safety risks. Future research should focus on optimizing stem cell selection and processing, designing robust clinical trials to evaluate long-term safety and efficacy, exploring combinatorial approaches with existing therapies, and developing advanced biomaterials to enhance transplantation success. Additionally, monitoring post-transplant cell survival and functionality, along with identifying epilepsy-specific biomarkers, will be crucial to refining the precision and safety of stem cell-based therapies.<\/jats:p>","DOI":"10.3389\/fneur.2025.1596484","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:27:43Z","timestamp":1755847663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Rewiring the seizing brain: stem cell grafts as neuromodulatory architects in epilepsy therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Zijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5582\/irdr.2024.01058","article-title":"Extrachromosomal DNA: molecular perspectives in aging and neurodegenerative diseases","volume":"13","author":"Ma","year":"2024","journal-title":"Intractable Rare Dis Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/bst.2024.01365","article-title":"Serum proteomics reveals early biomarkers of Alzheimer's disease: the dual role of APOE-epsilon4","volume":"19","author":"Ma","year":"2025","journal-title":"Biosci Trends"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus--report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/epi.13475","article-title":"Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus","volume":"57","author":"Aguglia","year":"2016","journal-title":"Epilepsia"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/14737175.2025.2524103","article-title":"Therapeutic approaches for super-refractory status epilepticus: an update of the literature","volume":"25","author":"Hu","year":"2025","journal-title":"Expert Rev Neurother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitkanen","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1528-1157.2003.32701.x","article-title":"A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories","volume":"44","author":"de Lanerolle","year":"2003","journal-title":"Epilepsia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"106058","DOI":"10.1016\/j.nbd.2023.106058","article-title":"Astrocyte-neuron circuits in epilepsy","volume":"179","author":"Purnell","year":"2023","journal-title":"Neurobiol Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neubiorev.2015.12.014","article-title":"GABA-ergic cell therapy for epilepsy: advances, limitations and challenges","volume":"62","author":"Shetty","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"118826","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: An updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.freeradbiomed.2004.08.021","article-title":"Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures","volume":"37","author":"Patel","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102248","DOI":"10.1016\/j.arr.2024.102248","article-title":"The effect of ferroptosis-related mitochondrial dysfunction in the development of temporal lobe epilepsy","volume":"96","author":"Su","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.7150\/thno.58632","article-title":"Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1397954","DOI":"10.3389\/fcell.2024.1397954","article-title":"Regulation of the Nrf2\/HO-1 axis by mesenchymal stem cells-derived extracellular vesicles: implications for disease treatment","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4103\/NRR.NRR-D-23-01444","article-title":"Pathogenesis, diagnosis, and treatment of epilepsy: electromagnetic stimulation-mediated neuromodulation therapy and new technologies","volume":"20","author":"Jiao","year":"2025","journal-title":"Neural Regen Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1093\/brain\/awab145","article-title":"Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy","volume":"144","author":"Bleakley","year":"2021","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"Loscher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3171\/2014.12.JNS141968","article-title":"Stereoelectroencephalography-guided radiofrequency thermocoagulation in the epileptogenic zone: a retrospective study on 89 cases","volume":"123","author":"Cossu","year":"2015","journal-title":"J Neurosurg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"9636897231158967","DOI":"10.1177\/09636897231158967","article-title":"Stem cells: recent developments redefining epilepsy therapy","volume":"32","author":"Alayli","year":"2023","journal-title":"Cell Transplant"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/biomedicines12061350","article-title":"Neuronal cell differentiation of iPSCs for the clinical treatment of neurological diseases","volume":"12","author":"Lee","year":"2024","journal-title":"Biomedicine"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.stem.2023.08.013","article-title":"Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy","volume":"30","author":"Bershteyn","year":"2023","journal-title":"Cell Stem Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","article-title":"GABAergic interneurons in the neocortex: from cellular properties to circuits","volume":"91","author":"Tremblay","year":"2016","journal-title":"Neuron"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"13243","DOI":"10.3390\/ijms222413243","article-title":"Human stem cell-derived GABAergic interneurons establish efferent synapses onto host neurons in rat epileptic Hippocampus and inhibit spontaneous recurrent seizures","volume":"22","author":"Waloschkova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yebeh.2019.04.042","article-title":"Novel therapies for epilepsy in the pipeline","volume":"97","author":"Mesraoua","year":"2019","journal-title":"Epilepsy Behav"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ana.21788","article-title":"Slowed progression in models of Huntington disease by adipose stem cell transplantation","volume":"66","author":"Lee","year":"2009","journal-title":"Ann Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1528-1167.2011.03182.x","article-title":"A cell-free extract from human adipose stem cells protects mice against epilepsy","volume":"52","author":"Jeon","year":"2011","journal-title":"Epilepsia"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"147121","DOI":"10.1016\/j.brainres.2020.147121","article-title":"Adipose-derived stem cell transplantation improves learning and memory via releasing neurotrophins in rat model of temporal lobe epilepsy","volume":"1750","author":"Wang","year":"2021","journal-title":"Brain Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1007\/s12035-025-04756-1","article-title":"Exosomal lncRNA RMRP-shuttled by olfactory mucosa-mesenchymal stem cells suppresses microglial Pyroptosis to improve spinal cord injury via EIF4A3\/SIRT1","volume":"62","author":"Wang","year":"2025","journal-title":"Mol Neurobiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"109865","DOI":"10.1016\/j.isci.2024.109865","article-title":"SENP1 facilitates OM-MSC differentiation through activating OPTN-mediated mitophagy to mitigate the neurologic impairment following ICH","volume":"27","author":"He","year":"2024","journal-title":"iScience"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1742-2094-6-39","article-title":"Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain","volume":"6","author":"Ryu","year":"2009","journal-title":"J Neuroinflammation"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21249683","article-title":"The anti-inflammatory properties of mesenchymal stem cells in epilepsy: possible treatments and future perspectives","volume":"21","author":"Salari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/5584_2020_592","article-title":"Embryonic stem cells in clinical trials: Current overview of developments and challenges","volume":"1312","author":"Golchin","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/kisup.2011.15","article-title":"Biology of stem cells: an overview","volume":"1","author":"Chagastelles","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.7507\/1001-5515.201804045","article-title":"Study and application of multidirectional differentiation potential of dental pulp stem cells","volume":"36","author":"Ge","year":"2019","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-023-02919-2","article-title":"Human iPSC-derived glia models for the study of neuroinflammation","volume":"20","author":"Stoberl","year":"2023","journal-title":"J Neuroinflammation"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10092319","article-title":"Induced pluripotent stem cells (iPSCs)-roles in regenerative therapies, disease modelling and drug screening","volume":"10","author":"Aboul-Soud","year":"2021","journal-title":"Cells"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13287-025-04217-5","article-title":"Generation of phenotypically stable and functionally mature human bone marrow MSCs derived Schwann cells via the induction of human iPSCs-derived sensory neurons","volume":"16","author":"Pan","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/jcbfm.2011.187","article-title":"Stem cell therapy for cerebral ischemia: from basic science to clinical applications","volume":"32","author":"Abe","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.cellbio.17.1.435","article-title":"Embryo-derived stem cells: of mice and men","volume":"17","author":"Smith","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stem.2024.01.009","article-title":"Hallmarks of totipotent and pluripotent stem cell states","volume":"31","author":"Du","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.jmb.2015.05.004","article-title":"Biomechanical origins of muscle stem cell signal transduction","volume":"428","author":"Morrissey","year":"2016","journal-title":"J Mol Biol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41586-024-07238-x","article-title":"Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity","volume":"628","author":"Ross","year":"2024","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-023-05739-9","article-title":"Chemically defined cytokine-free expansion of human haematopoietic stem cells","volume":"615","author":"Sakurai","year":"2023","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2174\/1871527320666210218085816","article-title":"A review on hematopoietic stem cell treatment for epilepsy","volume":"20","author":"Ghanta","year":"2021","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.ctdb.2020.11.002","article-title":"Ontogeny of adult neural stem cells in the mammalian brain","volume":"142","author":"Bond","year":"2021","journal-title":"Curr Top Dev Biol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"146615","DOI":"10.1016\/j.brainres.2019.146615","article-title":"The neural stem cell secretome and its role in brain repair","volume":"1729","author":"Willis","year":"2020","journal-title":"Brain Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.31083\/j.jin.2020.01.1142","article-title":"Neural stem cell secretome and its role in the treatment of neurodegenerative disorders","volume":"19","author":"Zhang","year":"2020","journal-title":"J Integr Neurosci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1074\/mcp.O115.052704","article-title":"Neural stem cells (NSCs) and proteomics","volume":"15","author":"Shoemaker","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"114142","DOI":"10.1016\/j.expneurol.2022.114142","article-title":"The neural stem cell secretome across neurodevelopment","volume":"355","author":"Dause","year":"2022","journal-title":"Exp Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"Rodriguez-Fuentes","year":"2021","journal-title":"Arch Med Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12565-024-00781-7","article-title":"Dental stem cells improve memory and reduce cell death in rat seizure model","volume":"100","author":"Shoja","year":"2024","journal-title":"Anat Sci Int"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.clineuro.2008.01.014","article-title":"The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders","volume":"110","author":"Slavin","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1741-7015-9-52","article-title":"Clinical trials for stem cell therapies","volume":"9","author":"Trounson","year":"2011","journal-title":"BMC Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","article-title":"Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury","volume":"261","author":"Donega","year":"2014","journal-title":"Exp Neurol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"624640","DOI":"10.1155\/2014\/624640","article-title":"Intraperitoneal infusion of mesenchymal stem\/stromal cells prevents experimental autoimmune uveitis in mice","volume":"2014","author":"Oh","year":"2014","journal-title":"Mediat Inflamm"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1017\/erm.2014.8","article-title":"The current landscape of adipose-derived stem cells in clinical applications","volume":"16","author":"Lim","year":"2014","journal-title":"Expert Rev Mol Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/stem.1909","article-title":"Concise reviews: characteristics and potential applications of human dental tissue-derived mesenchymal stem cells","volume":"33","author":"Liu","year":"2015","journal-title":"Stem Cells"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25158492","article-title":"Olfactory Ecto-mesenchymal stem cells in modeling and treating Alzheimer's disease","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4062\/biomolther.2019.065","article-title":"Differentiation of human mesenchymal stem cells towards neuronal lineage: clinical trials in nervous system disorders","volume":"28","author":"Hernandez","year":"2020","journal-title":"Biomol Ther (Seoul)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/1574888x09666140115114350","article-title":"Induced human bone marrow stromal cells differentiate into neural cells by bFGF and cocultured with olfactory ensheathing cells","volume":"9","author":"Ni","year":"2014","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2018.12.011","article-title":"Human olfactory stem cells: as a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease","volume":"696","author":"Alizadeh","year":"2019","journal-title":"Neurosci Lett"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-62703-574-3_10","article-title":"Isolation of adult stem cells from the human olfactory mucosa","volume":"1059","author":"Feron","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"a022376","DOI":"10.1101\/cshperspect.a022376","article-title":"Interneuron transplantation as a treatment for epilepsy","volume":"5","author":"Hunt","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"15472","DOI":"10.1073\/pnas.0900141106","article-title":"Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice","volume":"106","author":"Baraban","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2018.10.009","article-title":"Development and functional diversification of cortical interneurons","volume":"100","author":"Lim","year":"2018","journal-title":"Neuron"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1242\/dev.132852","article-title":"Cortical interneuron development: a tale of time and space","volume":"144","author":"Hu","year":"2017","journal-title":"Development"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"22050","DOI":"10.1038\/s41598-021-01270-x","article-title":"Human stem cell-derived GABAergic neurons functionally integrate into human neuronal networks","volume":"11","author":"Gonzalez-Ramos","year":"2021","journal-title":"Sci Rep"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1523\/JNEUROSCI.21-20-08108.2001","article-title":"Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease","volume":"21","author":"Akerud","year":"2001","journal-title":"J Neurosci"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/exnr.1999.7175","article-title":"Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor","volume":"160","author":"Hoane","year":"1999","journal-title":"Exp Neurol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"E5665","DOI":"10.1073\/pnas.1604263113","article-title":"Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus","volume":"113","author":"Varvel","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-018-0126-4","article-title":"Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e70027","DOI":"10.1111\/jnc.70027","article-title":"Exosome-derived CDC42 from hypoxia-pretreated neural stem cells inhibits ACSL4-related ferroptosis to alleviate vascular injury in Parkinson's disease mice models","volume":"169","author":"Li","year":"2025","journal-title":"J Neurochem"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.ymthe.2024.08.004","article-title":"Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency","volume":"32","author":"Rybova","year":"2024","journal-title":"Mol Ther"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","article-title":"Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy","volume":"495","author":"de Lanerolle","year":"1989","journal-title":"Brain Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7554\/eLife.40750","article-title":"Altered hippocampal interneuron activity precedes ictal onset","volume":"7","author":"Miri","year":"2018","journal-title":"eLife"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","article-title":"hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice","volume":"15","author":"Cunningham","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1073\/pnas.1814185115","article-title":"Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration","volume":"116","author":"Upadhya","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11065-015-9313-x","article-title":"Theory of mind in patients with epilepsy: a systematic review and Meta-analysis","volume":"26","author":"Stewart","year":"2016","journal-title":"Neuropsychol Rev"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hipo.20594","article-title":"Decreased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy","volume":"20","author":"Hattiangady","year":"2010","journal-title":"Hippocampus"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"a022772","DOI":"10.1101\/cshperspect.a022772","article-title":"Mechanisms responsible for cognitive impairment in epilepsy","volume":"5","author":"Lenck-Santini","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41583-022-00599-0","article-title":"The role of inhibitory circuits in hippocampal memory processing","volume":"23","author":"Topolnik","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.14336\/AD.2020.1020","article-title":"Hippocampal neural stem cell grafting after status epilepticus alleviates chronic epilepsy and abnormal plasticity, and maintains better memory and mood function","volume":"11","author":"Hattiangady","year":"2020","journal-title":"Aging Dis"},{"key":"ref95","volume-title":"Pioneering stem cell therapy offers new Hope for epilepsy treatment","year":"2023"},{"key":"ref96","volume-title":"Neurona therapeutics presents positive clinical update from NRTX-1001 cell therapy trial in adults with drug-resistant focal epilepsy at American Academy of Neurology (AAN) 2024 annual meeting","year":"2024"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat Cell Biol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/atm.2017.03.50","article-title":"Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science","volume":"5","author":"Beer","year":"2017","journal-title":"Ann Transl Med"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5582\/bst.2024.01306","article-title":"Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease","volume":"18","author":"Ma","year":"2024","journal-title":"Biosci Trends"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7593402","article-title":"Dental stem cell-derived Secretome\/conditioned medium: the future for regenerative therapeutic applications","volume":"2020","author":"El Moshy","year":"2020","journal-title":"Stem Cells Int"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"965849","DOI":"10.1155\/2014\/965849","article-title":"Prospect of stem cell conditioned medium in regenerative medicine","volume":"2014","author":"Pawitan","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/stem.446","article-title":"Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy","volume":"28","author":"Waldau","year":"2010","journal-title":"Stem Cells"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1523\/JNEUROSCI.0288-20.2020","article-title":"Induction of BDNF expression in layer II\/III and layer V neurons of the motor cortex is essential for motor learning","volume":"40","author":"Andreska","year":"2020","journal-title":"J Neurosci"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5966\/sctm.2012-0050","article-title":"Neural stem cell grafting counteracts hippocampal injury-mediated impairments in mood, memory, and neurogenesis","volume":"1","author":"Hattiangady","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-023-03458-6","article-title":"Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy","volume":"14","author":"Liu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","article-title":"Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke","volume":"54","author":"Shi","year":"2021","journal-title":"Immunity"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Ela","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2016.11.011","article-title":"Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury","volume":"60","author":"Drommelschmidt","year":"2017","journal-title":"Brain Behav Immun"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fncel.2017.00055","article-title":"MSCs-derived exosomes and Neuroinflammation, neurogenesis and therapy of traumatic brain injury","volume":"11","author":"Yang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40001-025-02344-6","article-title":"Olfactory mucosa-mesenchymal stem cells with overexpressed Nrf2 modulate angiogenesis and exert anti-inflammation effect in an in vitro traumatic brain injury model","volume":"30","author":"Chen","year":"2025","journal-title":"Eur J Med Res"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arr.2010.08.005","article-title":"MSCs: biological characteristics, clinical applications and their outstanding concerns","volume":"10","author":"Si","year":"2011","journal-title":"Ageing Res Rev"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.7150\/thno.33872","article-title":"Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice","volume":"9","author":"Xian","year":"2019","journal-title":"Theranostics"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"E3536","DOI":"10.1073\/pnas.1703920114","article-title":"Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus","volume":"114","author":"Long","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.nbd.2004.08.008","article-title":"Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus","volume":"17","author":"Hattiangady","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.expneurol.2008.04.040","article-title":"Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy","volume":"212","author":"Hattiangady","year":"2008","journal-title":"Exp Neurol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbi.2015.12.021","article-title":"Xenograft of human umbilical mesenchymal stem cells from Wharton's jelly as a potential therapy for rat pilocarpine-induced epilepsy","volume":"54","author":"Huang","year":"2016","journal-title":"Brain Behav Immun"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cne.903520404","article-title":"Hippocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: visualization after retrograde transport of biocytin","volume":"352","author":"Okazaki","year":"1995","journal-title":"J Comp Neurol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2018.02.008","article-title":"Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus","volume":"141","author":"Fukumura","year":"2018","journal-title":"Epilepsy Res"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12013-011-9219-z","article-title":"Transplantation of neural stem cells overexpressing cardiotrophin-1 inhibits sprouting of hippocampal mossy fiber in a rat model of status epilepticus","volume":"61","author":"Shu","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3389\/fneur.2018.01023","article-title":"Is mossy Fiber sprouting a potential therapeutic target for epilepsy?","volume":"9","author":"Cavarsan","year":"2018","journal-title":"Front Neurol"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1528-1167.2010.02930.x","article-title":"Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus","volume":"52","author":"Paradiso","year":"2011","journal-title":"Epilepsia"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2174\/138161212799859611","article-title":"Neural stem cell niches in health and diseases","volume":"18","author":"Decimo","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yebeh.2013.12.001","article-title":"Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?","volume":"38","author":"Shetty","year":"2014","journal-title":"Epilepsy Behav"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1523\/JNEUROSCI.4682-14.2015","article-title":"Autocrine action of BDNF on dendrite development of adult-born hippocampal neurons","volume":"35","author":"Wang","year":"2015","journal-title":"J Neurosci"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"14318","DOI":"10.1523\/JNEUROSCI.0709-12.2012","article-title":"BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission","volume":"32","author":"Waterhouse","year":"2012","journal-title":"J Neurosci"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-022-02627-3","article-title":"Single cell profiling of CD45(+) spinal cord cells reveals microglial and B cell heterogeneity and crosstalk following spinal cord injury","volume":"19","author":"Fisher","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1111\/ejn.14969","article-title":"The effects of microglia- and astrocyte-derived factors on neurogenesis in health and disease","volume":"54","author":"Araki","year":"2021","journal-title":"Eur J Neurosci"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.rceng.2023.11.002","article-title":"New era of mesenchymal stem cell-based medicine: basis, challenges and prospects","volume":"223","author":"Vizoso","year":"2023","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1421854","DOI":"10.3389\/fimmu.2024.1421854","article-title":"Advances and clinical challenges of mesenchymal stem cell therapy","volume":"15","author":"Mei","year":"2024","journal-title":"Front Immunol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","article-title":"The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment","volume":"13","author":"Heris","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"e35836","DOI":"10.1016\/j.heliyon.2024.e35836","article-title":"Advancements and challenges in stem cell transplantation for regenerative medicine","volume":"10","author":"Wei","year":"2024","journal-title":"Heliyon"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25179695","article-title":"Navigating the Neuroimmunomodulation frontier: pioneering approaches and promising horizons-a comprehensive review","volume":"25","author":"Krsek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13287-025-04438-8","article-title":"Pharmacological modulation of stem cells signaling pathway for therapeutic applications","volume":"16","author":"Alnasser","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1021\/acssensors.5c00024","article-title":"Smart bioelectronics for real-time diagnosis and therapy of body organ functions","volume":"10","author":"Guo","year":"2025","journal-title":"ACS Sens"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/bioengineering10070857","article-title":"Assessing Tumorigenicity in stem cell-derived therapeutic products: a critical step in safeguarding regenerative medicine","volume":"10","author":"Wang","year":"2023","journal-title":"Bioengineering (Basel)."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"11","DOI":"10.18103\/mra.v11i11.4784","article-title":"The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy","volume":"11","author":"Moy","year":"2023","journal-title":"Med Res Arch"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.stemcr.2021.05.021","article-title":"Recognizing the ethical implications of stem cell research: a call for broadening the scope","volume":"16","author":"Assen","year":"2021","journal-title":"Stem Cell Reports"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4103\/NRR.NRR-D-23-01620","article-title":"The role of axon guidance molecules in the pathogenesis of epilepsy","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen Res"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1634\/stemcells.2007-0313","article-title":"Concise review: prospects of stem cell therapy for temporal lobe epilepsy","volume":"25","author":"Shetty","year":"2007","journal-title":"Stem Cells"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/bioengineering11050487","article-title":"Updated toolbox for assessing neuronal network reconstruction after cell therapy","volume":"11","author":"Gonzalez-Ramos","year":"2024","journal-title":"Bioengineering (Basel)"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/ma17020456","article-title":"Biomaterials for drug delivery and human applications","volume":"17","author":"Trucillo","year":"2024","journal-title":"Materials (Basel)"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/stcltm\/szae059","article-title":"Recent progress in modeling and treating diabetes using stem cell-derived islets","volume":"13","author":"Maestas","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/dom.15375","article-title":"Efficacy of adipose-derived mesenchymal stem cell therapy in the treatment of chronic micro- and macrovascular complications of diabetes","volume":"26","author":"Miklosz","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.7150\/thno.95953","article-title":"Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's disease, Parkinson's disease, and stroke","volume":"14","author":"Zhou","year":"2024","journal-title":"Theranostics"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/jnnp-2023-332921","article-title":"Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease","volume":"95","author":"Jiang","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/stcltm\/szae011","article-title":"Stem cell derived extracellular vesicle therapy for multiple sclerosis, a systematic review and Meta-analysis of preclinical studies","volume":"13","author":"Barabadi","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cancers9110146","article-title":"Advances in precision medicine: tailoring individualized therapies","volume":"9","author":"Matchett","year":"2017","journal-title":"Cancers (Basel)"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/dvdy.24582","article-title":"MicroRNA-induced silencing in epilepsy: opportunities and challenges for clinical application","volume":"247","author":"Tiwari","year":"2018","journal-title":"Dev Dyn"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s13311-021-01081-y","article-title":"Gene editing and modulation: the holy grail for the genetic epilepsies?","volume":"18","author":"Carpenter","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"142","DOI":"10.31083\/j.fbl2904142","article-title":"Deciphering the enigma of neuron-glial interactions in neurological disorders","volume":"29","author":"Ahmad","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"107781","DOI":"10.1016\/j.neuropharm.2019.107781","article-title":"Stem cells: a path towards improved epilepsy therapies","volume":"168","author":"Lybrand","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2015.08.003","article-title":"Neuronal migration disorders: focus on the cytoskeleton and epilepsy","volume":"92","author":"Stouffer","year":"2016","journal-title":"Neurobiol Dis"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.33588\/rn.66S01.2017529","article-title":"Epilepsy, cognition and ketogenic diet","volume":"66","author":"Garcia-Penas","year":"2018","journal-title":"Rev Neurol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cells11244129","article-title":"Therapeutic potential of mesenchymal stem cells in the treatment of epilepsy and their interaction with Antiseizure medications","volume":"11","author":"Tesiye","year":"2022","journal-title":"Cells"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/1028415X.2019.1627769","article-title":"Ketogenic diet: overview, types, and possible anti-seizure mechanisms","volume":"24","author":"Barzegar","year":"2021","journal-title":"Nutr Neurosci"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/acn3.51815","article-title":"Pulvinar neuromodulation for seizure monitoring and network modulation in temporal plus epilepsy","volume":"10","author":"Vakilna","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.neuron.2022.12.014","article-title":"Human cortical interneurons optimized for grafting specifically integrate, abort seizures, and display prolonged efficacy without over-inhibition","volume":"111","author":"Zhu","year":"2023","journal-title":"Neuron"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.advms.2016.12.004","article-title":"Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study","volume":"62","author":"Hlebokazov","year":"2017","journal-title":"Adv Med Sci"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.1002\/term.2334","article-title":"Safety and seizure control in patients with mesial temporal lobe epilepsy treated with regional superselective intra-arterial injection of autologous bone marrow mononuclear cells","volume":"12","author":"DaCosta","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7104243","article-title":"Intrathecal infusion of autologous adipose-derived regenerative cells in autoimmune refractory epilepsy: evaluation of safety and efficacy","volume":"2020","author":"Szczepanik","year":"2020","journal-title":"Stem Cells Int"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s12015-023-10673-4","article-title":"Bone marrow nucleated cells and bone marrow-derived CD271+ mesenchymal stem cell in treatment of encephalopathy and drug-resistant epilepsy","volume":"20","author":"Milczarek","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"106736","DOI":"10.1016\/j.clineuro.2021.106736","article-title":"Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients","volume":"207","author":"Hlebokazov","year":"2021","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1596484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:27:46Z","timestamp":1755847666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1596484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":164,"alternative-id":["10.3389\/fneur.2025.1596484"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1596484","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"1596484"}}